LOXL1, LOXL2, LOXL3, and LOXL4 expression levels were also found to increase progressively in astrocytomas from grades 2 to 4, proving highest in GBM, and significantly higher relative to non-neoplastic brain tissue. This evidence concerns the gene LOXL3 and astrocytoma (excluding glioblastoma).